Trial Details

NOT_YET_RECRUITING
Basic Information
Clinical ID c1298
Identifier NCT05976802
Trial Title Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: High dose budesonide rectal foam|DRUG: Low dose budesonide rectal foam|DRUG: Matching placebo rectal foam
Participant Information
Sponsor Bausch Health Americas, Inc.
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2025-06-24
Primary Completion Date 2025-06-25
Completion Date 2025-06-25